BACKGROUND: We analyzed the clinicopathological features and prognosis in patients with periocular sebaceous gland carcinoma. METHODS: Retrospectively, we studied the records of 24 cases of sebaceous gland carcinoma treated in our clinic between 1999 and 2004. The reviewed data included demographic information, initial clinical and histopathological diagnosis, anatomic tumor location, details of treatment, tumor involvement of resection margin, and outcomes such as local recurrence, distant metastasis and survival. RESULTS: Local recurrence developed in 6 cases (25%) at a median of 20 months from initial diagnosis. Only 2 patients (8.3%) died of systemic metastasis to brain and bone from primary lacrimal gland carcinoma. The local recurrenc...
Article first published online: 3 FEB 2004Background. Sebaceous carcinoma (SC) accounts for 1% to 5....
Background: Eyelid carcinoma is the most common malignant lesion of eyelid region, and may involve e...
Background/aims: To assess epidemiological tumour features, risk factors, clinical management and ou...
BACKGROUND: Sebaceous gland carcinomas affect elderly patients, the median age at diagnosis being ov...
Sebaceous gland carcinoma, commonly arises in the periocular area, is an uncommon condition. It repr...
AbstractSebaceous gland carcinoma (SGC) is a rare tumour occurring at periocular and extra-ocular si...
Abstract BACKGROUND: The reports in the literature indicate that extraocular sebaceous carcinoma (S...
Sebaceous carcinoma (SC) is a rare type of cancer that aggressive which develops from the sebaceous ...
Yangfan Xu,1,2,* Fang Li,1,2,* Renbing Jia,1,2 Xianqun Fan1,2 1Department of Ophthalmology, Shangha...
Sebaceous carcinoma of the ocular adnexa is a malignant neoplasm which can exhibit aggressive local ...
Sebaceous carcinoma (SC) is a rare skin cancer which usually occurs on the head and neck, and has a ...
ABSTRACT: Background. The purpose of this study was to describe the incidence of nodal disease in se...
Background: Sebaceous gland tumour is the second commonest tumour of meibomian glands of eye. Presen...
Abstract: Sebaceous gland carcinoma of the eyelid is a very rare, slow growing tumor arising from th...
<p>Purpose: To investigate the epidemiology and clinicopathological management for ocular sebaceous ...
Article first published online: 3 FEB 2004Background. Sebaceous carcinoma (SC) accounts for 1% to 5....
Background: Eyelid carcinoma is the most common malignant lesion of eyelid region, and may involve e...
Background/aims: To assess epidemiological tumour features, risk factors, clinical management and ou...
BACKGROUND: Sebaceous gland carcinomas affect elderly patients, the median age at diagnosis being ov...
Sebaceous gland carcinoma, commonly arises in the periocular area, is an uncommon condition. It repr...
AbstractSebaceous gland carcinoma (SGC) is a rare tumour occurring at periocular and extra-ocular si...
Abstract BACKGROUND: The reports in the literature indicate that extraocular sebaceous carcinoma (S...
Sebaceous carcinoma (SC) is a rare type of cancer that aggressive which develops from the sebaceous ...
Yangfan Xu,1,2,* Fang Li,1,2,* Renbing Jia,1,2 Xianqun Fan1,2 1Department of Ophthalmology, Shangha...
Sebaceous carcinoma of the ocular adnexa is a malignant neoplasm which can exhibit aggressive local ...
Sebaceous carcinoma (SC) is a rare skin cancer which usually occurs on the head and neck, and has a ...
ABSTRACT: Background. The purpose of this study was to describe the incidence of nodal disease in se...
Background: Sebaceous gland tumour is the second commonest tumour of meibomian glands of eye. Presen...
Abstract: Sebaceous gland carcinoma of the eyelid is a very rare, slow growing tumor arising from th...
<p>Purpose: To investigate the epidemiology and clinicopathological management for ocular sebaceous ...
Article first published online: 3 FEB 2004Background. Sebaceous carcinoma (SC) accounts for 1% to 5....
Background: Eyelid carcinoma is the most common malignant lesion of eyelid region, and may involve e...
Background/aims: To assess epidemiological tumour features, risk factors, clinical management and ou...